Swissmedic 修订 Form DMF,新增经 IncaMail 加密向 DMF 持有人发送问题的选项
Modification of the “Form DMF”
Swissmedic 修订 Form DMF,新增通过 Swiss Post 的 IncaMail 以加密形式直接向药品主文件(DMF)持有人发送 Restricted Part 相关问题的送达方式,修订版自 2026 年 11 月 1 日起生效。
Modification of the “Form DMF”
Encrypted e-mail delivery to DMF holder via IncaMail
01.11.2026
Swissmedic is introducing the possibility of sending questions on the Restricted Part of the application documentation directly to the Drug Master File (DMF) holder in encrypted form via IncaMail¹.
The authorisation holder and the DMF holder can now give their agreement to this delivery method in the “Form DMF”. Delivery by post, as previously, remains an option.
The revised “Form DMF” is valid with effect from 1 November 2026.
1IncaMail is an e-mail service provided by Swiss Post for encrypted transmission of confidential documents. Notification via an IncaMail may seem unusual for recipients outside of Switzerland in particular. The message is accessed via a link in the notification e-mail.
来源:Swissmedic 药品质量与 GMP 更新 · swissmedic.ch